Simply Wall Street Earnings
Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale
Thermo Fisher Scientific (TMO) stock has gained 20.7% over the last year and appears modestly undervalued by about 7.6% according to a Discounted Cash Flow (DCF) model, suggesting it's close to its intrinsic value. While a recent sale of its microbiology business and focus on proteomics and precision medicine support future cash generation, the P/E ratio indicates it …